Psyence Biomedical Ltd.
NASDAQPBM short interest surged 54% over the past week to 3.47% of float, though daily shares fell 4.7%. Cost to borrow remains elevated at 305%, down from 407% late April.
PBM heads into mid-May in one of the stranger post-squeeze configurations in the small-cap biotech space: short interest has collapsed back to normal levels, yet the cost to borrow remains at a near-record 324%. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PBM — free to start on ORTEX.
Sign up for free →Open PBM on ORTEXSnapshot as of 28 Jun 2026
Pulses are triggered by ORTEX's live data feeds. The full signal history, thresholds, and alerts are on ORTEX.
Live PBM data →